.jpg)
.png)
All
Pursuant to the advice of the Chapter of the National Lipid Association, the following updates to the Bylaws are proposed to the NLA membership for adoption at the NLA Business Meeting on May 18, 2019. The purpose of the update is to restore the position of the at-large directors on the chapter... more
According to the second part of the joint scientific statement by the National Lipid Association (NLA), American Society for Metabolic and Bariatric Surgery (ASMBS), and Obesity Medicine Association (OMA), bariatric surgery improves multiple cardiovascular risk factors, including blood... more
The Pacific Chapter of the National Lipid Association continues to be demographically and geographically diverse. We currently have 424 members (about 15 percent of the NLA membership in the U.S.) who are scattered among nine states comprising roughly 1,434,027 square miles of land. This translates... more
On December 19, 2024, Ionis Pharmaceuticals, Inc. received FDA approval for TRYNGOLZA (Olezarsen) as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).
National Lipid Association Announces Late-Breaking Abstract Presentations at NLA 2020 Virtual Scientific Sessions JACKSONVILLE, Fla. – (December 10, 2020) – The National Lipid Association announced today that it will feature three key late breaking scientific abstract presentations at its 2020... more
The National Lipid Association and the Foundation are thankful once again for another successful year of meetings and fundraising. But we still have much work to do. The Foundation hosted the NLA’s 15th Anniversary Celebration Gala this past May in conjunction with the NLA Annual... more
The Foundation of the National Lipid Association continues to make strides to help educate and promote clinical lipidology — both to clinicians and to the public. In the last Foundation Update, we discussed the launch of “Cholesterol Counts,” an unbranded cholesterol awareness campaign geared... more